Authorised representative (AR)

UNI Rainbow Limited

Hong Kong MDACS·12 represented devices·7 applicants·Mar 10, 2010May 21, 2024
12
Total devices
7
Applicants
2010
First representation
2024
Most recent
AR overview
Bilingual authorised representative information and contact details
Authorised representative (EN)
UNI Rainbow Limited
Phone
26969278
Timeline
First representation
Mar 10, 2010
Most recent
May 21, 2024
Risk class distribution
III
1
IV
11
Applicant partnerships
Top manufacturers represented by this AR
Unknown Applicant
0
Recent registrations
Latest 15 MDACS listings represented by UNI Rainbow Limited
DeviceRisk classApplicantRegistered
Stent/Grafts, Vascular, Aortic
支架/移植物,血管,主动脉
IVBeijing Med-Zenith Medical Scientific Corporation Limited
北京迈迪顶峰医疗科技股份有限公司
May 21, 2024
Catheters, Cardiac, Septostomy
导管、心脏、隔膜造口术
IVBaylis Medical Company Inc.
Baylis Medical Company Inc.
Sep 03, 2021
Radiofrequency Therapy Systems, Tissue Ablation
射频治疗系统,组织消融
IIIBaylis Medical Company Inc.
Baylis Medical Company Inc.
Sep 03, 2021
Stents, Vascular, Aorta, Balloon Expandable
支架,血管支架,主动脉支架,球囊扩张
IVNuMED, Inc.
Numed, Inc.
Jan 07, 2021
Catheters, Cardiac, Angiography
心脏导管,血管造影
IVNuMED, Inc.
Numed, Inc.
Jan 07, 2021
Catheters, Vascular, Stent Delivery, Aorta
导管、血管、支架输送、主动脉
IVNuMED, Inc.
Numed, Inc.
Jan 07, 2021
Stents, Vascular, Aorta, Balloon Expandable
支架,血管支架,主动脉支架,球囊扩张
IVNuMED, Inc.
Numed, Inc.
Jan 07, 2021
Occluders, Vascular, Presacral Bleeding
闭塞器、血管性、骶前出血
IVVascular Innovations Co., Ltd.
Vascular Innovations Co., Ltd.
Jun 02, 2016
Stents, Vascular, Coronary, Balloon-Expandable
支架,血管支架,冠状动脉支架,球囊扩张支架
IVQualiMed Innovative Medizinprodukte GmbH
Qualimed Innovative Medizinprodukte Gmbh
Apr 12, 2013
Stents, Vascular, Coronary, Balloon-Expandable
支架,血管支架,冠状动脉支架,球囊扩张支架
IVQualiMed Innovative Medizinprodukte GmbH
Qualimed Innovative Medizinprodukte Gmbh
Mar 08, 2013
Occluders, Cardiac Septum
封堵器,心脏隔膜
IVOcclutech GmbH
Occlutech GmbH
Mar 10, 2010
Occluders, Cardiac Septum
封堵器,心脏隔膜
IV-Mar 10, 2010
About this profile

UNI Rainbow Limited serves as the authorised representative for 12 medical devices in Hong Kong's MDACS framework. Analyse applicant partnerships, risk class exposure, and recent regulatory activity to understand their market footprint.